510(k) Report

510(k) · Cleared

Recalled · Class II · 2020

microTargeting Guideline 4000 5.0 System

K183123510(k) SpecialCleared Dec 20, 201837-day reviewClass II21 CFR 882.1330Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

FHC, Inc. · GZL Electrode, Depth

Cleared on Dec 20, 2018 as substantially equivalent to K071364 (FHC, Inc., 2007) after a 37-day review. Its family tree reaches back 3 generations to 1997. 1 later device descends from it. It has been recalled once.

Decided
Dec 20, 2018
Review
37 days
Class
Class II
Product code
GZL
Recalls
1
Predicates
1

Its longest line of descent runs back 3 generations to K970943 (1997). 4 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1998: 1 other ancestor2025: 1 descendant clearedK970943 · Guideline System · Axon Instruments, Inc. · 1997K993622 · Neurotrek Physiological Navigation System for Neurosurgery · Alpha Omega, Ltd. · 2000K071364 · Microtargeting Guideline 4000 · FHC, Inc. · 2007 · recalled1995200020052010201520202025
Other ancestors, by generationDescendants, by generation 3 generations back: 1 other ancestor 1 generation forward: 1 descendant K071364 · Microtargeting Guideline 4000 · FHC, Inc. · 2007 · recalledK993622 · Neurotrek Physiological Navigation System for Neurosurgery · Alpha Omega, Ltd. · 2000K970943 · Guideline System · Axon Instruments, Inc. · 19970
  1. Root · 3 generations backK970943 Guideline SystemAxon Instruments, Inc. · 1997
  2. 2 generations backK993622 Neurotrek Physiological Navigation System for NeurosurgeryAlpha Omega, Ltd. · 2000
  3. 1 generation backK071364 Microtargeting Guideline 4000FHC, Inc. · 2007 · Recalled
  4. This deviceK183123 microTargeting Guideline 4000 5.0 SystemFHC, Inc. · 2018
  5. Descendant · cites it directly · 0 of its ownK250094 Atlas Stim Headbox (NK) (31-0601-0077); Atlas Stim Headbox…Neuralynx, Inc. · 2025

Most influential descendants

Showing 1 of 1 · See all
  • K250094Atlas Stim Headbox (NK) (31-0601-0077); Atlas Stim Headbox (Touchproof) (31-0601-0089)…Neuralynx, Inc. · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K970943Guideline SystemAxon Instruments, Inc.1997—
−2K993622Neurotrek Physiological Navigation System for NeurosurgeryAlpha Omega, Ltd.2000—
−1K071364Microtargeting Guideline 4000FHC, Inc.20071
0 (this device)K183123microTargeting Guideline 4000 5.0 SystemFHC, Inc.2018—
+1K250094Atlas Stim Headbox (NK) (31-0601-0077); Atlas Stim Headbox (Touchproof)…Neuralynx, Inc.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K183123, 1997–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZL device

  1. #1 K253970 Wovyn Depth Electrodescore 13.3 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K071364Microtargeting Guideline 4000
Summary page 4
…laims substantial equivalence: The microtargeting™ Guideline 4000™ 5.0 System is substantially equivalent to FHC, Inc.’s microTargeting® Guideline 4000 (K071364); decision date: July 25th 2007, product code: GZL. FHC Corporate & Manufacturing Tel: +1-207-666-8190 FHC Europe…
FHC, Inc.20071

Also cleared against K071364: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K250094Atlas Stim Headbox (NK) (31-0601-0077); Atlas Stim Headbox (Touchproof) (31-0601-0089)…Neuralynx, Inc.20250

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 17, 2020Class IIZ-2540-2020Component change controlAn electrical sub-circuit was not properly connected. Its purpose is to eliminate the possibility of interference with proper performance of the Guideline 5 Main Processing Unit, if an ESD event (greater than 6kV) were to occur.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 3 companies; a new generation was cleared every 7.5 years on median.
  • 1 of the 4 ancestors has a recall of any class.
  • Of its descendants, K250094 (Neuralynx, Inc., 2025) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K071364.

How does its category compare?

All GZL devices

GZL Electrode, Depth: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · GZL

2in 2025

2007: 32009: 12011: 12012: 12013: 12014: 12016: 22017: 42018: 32020: 12021: 32022: 32023: 32025: 22026 (partial year): 1
2007high 4 (2017) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZL

206in 2023

2007: 166 days median2017: 222 days median2018: 58 days median2021: 262 days median2022: 90 days median2023: 206 days median
2007high 262 (2021) · low 58 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZL

3in 2024

2008: 32009: 22014: 12021: 92024: 3
2007high 9 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZL

12in 2025

2008: 82009: 52010: 62011: 42012: 82013: 252014: 72015: 142016: 92017: 32018: 22019: 132020: 242021: 132022: 102023: 302024: 162025: 12
2007high 30 (2023) · low 0 (2007)2025

MAUDE reports naming product code GZL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007316600
20080—38
20091—25
20100—06
20111—04
20121—08
20131—025
20141—17
20150—014
20162—09
2017422203
201835802
20190—013
20201—024
20213262913
2022390010
20233206030
20240—316
20252—012
20261—0—

What is it indicated for?

The microTargeting™ Guideline 4000 5.0 System is intended to record and stimulate electrophysiological activity, as well as aid in the accurate placement of electrodes and other instruments.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K183123: microTargeting Guideline 4000 5.0 System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K183123

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026